Terms: = Kidney tumors AND MEN1, ENSG00000133895, 4221
102 results:
1. [Comparative analysis of bone complications/manifestations in sporadic and men1-related primary hyperparathyroidism].
Pylina SV; Eremkina AK; Elfimova AR; Gorbacheva AM; Mokrysheva NG
Probl Endokrinol (Mosk); 2024 Feb; 70(1):81-90. PubMed ID: 38433544
[TBL] [Abstract] [Full Text] [Related]
2. Expressions of Cushing's syndrome in multiple endocrine neoplasia type 1.
Simonds WF
Front Endocrinol (Lausanne); 2023; 14():1183297. PubMed ID: 37409236
[TBL] [Abstract] [Full Text] [Related]
3. Renal neuroendocrine tumors: clinical and molecular pathology with an emphasis on frequent association with ectopic Cushing syndrome.
Kasajima A; Pfarr N; von Werder A; Schwamborn K; Gschwend J; Din NU; Esposito I; Weichert W; Pavel M; Agaimy A; Klöppel G
Virchows Arch; 2023 Oct; 483(4):465-476. PubMed ID: 37405461
[TBL] [Abstract] [Full Text] [Related]
4. Tuberous sclerosis complex mutations in patients with pancreatic neuroendocrine tumors. Observations on phenotypic and treatment-related associations.
Navale P; Chatterjee D; Itani M; Trikalinos NA
Virchows Arch; 2023 Aug; 483(2):167-175. PubMed ID: 37354253
[TBL] [Abstract] [Full Text] [Related]
5. Blood-based Proteomic Signatures Associated With men1-related Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Wu R; Dennison JB; Peterson CB; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Jha S; Rivero JD; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM; Katayama H
J Clin Endocrinol Metab; 2023 Nov; 108(12):3260-3271. PubMed ID: 37307230
[TBL] [Abstract] [Full Text] [Related]
6. Mortality trends and geographic distribution of kidney cancer in Peru: a secondary analysis.
Torres-Roman JS; De la Cruz-Ku G; Juárez-Leon V; Calderón-Solano D; Bazalar-Palacios J; Vecchia C; Pinheiro PS
BMC Urol; 2023 Mar; 23(1):51. PubMed ID: 36991482
[TBL] [Abstract] [Full Text] [Related]
7. Germline- and Somatic-Inactivating FLCN Variants in Parathyroid Cancer and Atypical Parathyroid tumors.
Jha S; Welch J; Tora R; Lack J; Warner A; Del Rivero J; Sadowski SM; Nilubol N; Schmidt LS; Linehan WM; Weinstein LS; Simonds WF; Agarwal SK
J Clin Endocrinol Metab; 2023 Sep; 108(10):2686-2698. PubMed ID: 36935552
[TBL] [Abstract] [Full Text] [Related]
8. Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
Agaimy A; Kasajima A; Stoehr R; Haller F; Schubart C; Tögel L; Pfarr N; von Werder A; Pavel ME; Sessa F; Uccella S; La Rosa S; Klöppel G
Virchows Arch; 2023 Mar; 482(3):507-516. PubMed ID: 36690805
[TBL] [Abstract] [Full Text] [Related]
9. Rare duplication of the CDC73 gene and atypical hyperparathyroidism-jaw tumor syndrome: A case report and review of the literature.
Garrigues G; Batisse-Lignier M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Kelly A; Gay-Bellile M; Viala S; Bidet Y; Bignon YJ; Cavaillé M
Mol Genet Genomic Med; 2023 May; 11(5):e2133. PubMed ID: 36639964
[TBL] [Abstract] [Full Text] [Related]
10. Rare clinical manifestation of multiple endocrine neoplasia type 1.
Petriczko E; Marcinkiewicz K; Prokurat A; Sagan L; Malkowski B; Biczysko-Mokosa A; Horodnicka-Jozwa A; Andrysiak-Mamos E; Syrenicz A; Kostrzeba E; Walczak M
Neuro Endocrinol Lett; 2022 Nov; 43(4):199-207. PubMed ID: 36528881
[TBL] [Abstract] [Full Text] [Related]
11. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
12. Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
[TBL] [Abstract] [Full Text] [Related]
13. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
[TBL] [Abstract] [Full Text] [Related]
14. Two distinct classes of thymic tumors in patients with men1 show LOH at the men1 locus.
Mandl A; Welch JM; Kapoor G; Parekh VI; Schrump DS; Ripley RT; Walter MF; Del Rivero J; Jha S; Simonds WF; Jensen RT; Weinstein LS; Blau JE; Agarwal SK
Endocr Relat Cancer; 2021 Oct; 28(11):L15-L19. PubMed ID: 34515662
[TBL] [Abstract] [Full Text] [Related]
15. A Blood-based Polyamine Signature Associated With men1 Duodenopancreatic Neuroendocrine Tumor Progression.
Fahrmann JF; Wasylishen AR; Pieterman CRC; Irajizad E; Vykoukal J; Murage E; Wu R; Dennison JB; Krishna H; Peterson CB; Lozano G; Zhao H; Do KA; Halperin DM; Agarwal SK; Blau JE; Del Rivero J; Nilubol N; Walter MF; Welch JM; Weinstein LS; Vriens MR; van Leeuwaarde RS; van Treijen MJC; Valk GD; Perrier ND; Hanash SM
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4969-e4980. PubMed ID: 34318891
[TBL] [Abstract] [Full Text] [Related]
16. Familial Hyperparathyroidism.
Blau JE; Simonds WF
Front Endocrinol (Lausanne); 2021; 12():623667. PubMed ID: 33716975
[TBL] [Abstract] [Full Text] [Related]
17. Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid tumors.
Tavanti GS; Verdelli C; Morotti A; Maroni P; Guarnieri V; Scillitani A; Silipigni R; Guerneri S; Maggiore R; Mari G; Vicentini L; Dalino Ciaramella P; Vaira V; Corbetta S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670622
[TBL] [Abstract] [Full Text] [Related]
18. Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the men1 Syndrome - An International Consensus Statement.
Niederle B; Selberherr A; Bartsch DK; Brandi ML; Doherty GM; Falconi M; Goudet P; Halfdanarson TR; Ito T; Jensen RT; Larghi A; Lee L; Öberg K; Pavel M; Perren A; Sadowski SM; Tonelli F; Triponez F; Valk GD; O'Toole D; Scott-Coombes D; Thakker RV; Thompson GB; Treglia G; Wiedenmann B
Neuroendocrinology; 2021; 111(7):609-630. PubMed ID: 32971521
[TBL] [Abstract] [Full Text] [Related]
19. Multiple Endocrine Neoplasia Type 1 (men1) 5'UTR Deletion, in men1 Family, Decreases Menin Expression.
Kooblall KG; Boon H; Cranston T; Stevenson M; Pagnamenta AT; Rogers A; Grozinsky-Glasberg S; Richardson T; Flanagan DE; ; Taylor JC; Lines KE; Thakker RV
J Bone Miner Res; 2021 Jan; 36(1):100-109. PubMed ID: 32780883
[TBL] [Abstract] [Full Text] [Related]
20. Patients With men1 Are at an Increased Risk for Venous Thromboembolism.
Lee ME; Ortega-Sustache YM; Agarwal SK; Tepede A; Welch J; Mandl A; Bansal R; Tirosh A; Piaggi P; Cochran C; Simonds WF; Weinstein LS; Blau JE
J Clin Endocrinol Metab; 2021 Jan; 106(2):e460-e468. PubMed ID: 32756962
[TBL] [Abstract] [Full Text] [Related]
[Next]
